These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 7794953

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Structure-transport relationship for the intestinal small-peptide carrier: is the carbonyl group of the peptide bond relevant for transport?
    Schoenmakers RG, Stehouwer MC, Tukker JJ.
    Pharm Res; 1999 Jan; 16(1):62-8. PubMed ID: 9950280
    [Abstract] [Full Text] [Related]

  • 3. Stability and in vitro absorption of captopril, enalapril and lisinopril across the rat intestine.
    Zhou XH, Li Wan Po A.
    Biochem Pharmacol; 1994 Mar 29; 47(7):1121-6. PubMed ID: 8161340
    [Abstract] [Full Text] [Related]

  • 4. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
    Lin CJ, Akarawut W, Smith DE.
    Pharm Res; 1999 May 29; 16(5):609-15. PubMed ID: 10350000
    [Abstract] [Full Text] [Related]

  • 5. Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in rats.
    Lin JH, Chen IW, Ulm EH, Duggan DE.
    Drug Metab Dispos; 1988 May 29; 16(3):392-6. PubMed ID: 2900730
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells.
    Thwaites DT, Cavet M, Hirst BH, Simmons NL.
    Br J Pharmacol; 1995 Mar 29; 114(5):981-6. PubMed ID: 7780654
    [Abstract] [Full Text] [Related]

  • 7. Radioimmunoassay for the quantitation of lisinopril and enalaprilat.
    Worland PJ, Jarrott B.
    J Pharm Sci; 1986 May 29; 75(5):512-6. PubMed ID: 3016233
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG, Rao NM.
    Indian J Biochem Biophys; 1997 Dec 29; 34(6):524-8. PubMed ID: 9594434
    [Abstract] [Full Text] [Related]

  • 9. A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme.
    Andújar-Sánchez M, Cámara-Artigas A, Jara-Pérez V.
    Biophys Chem; 2004 Oct 01; 111(2):183-9. PubMed ID: 15381315
    [Abstract] [Full Text] [Related]

  • 10. Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopril and SQ 29,852.
    Friedman DI, Amidon GL.
    J Pharm Sci; 1989 Dec 01; 78(12):995-8. PubMed ID: 2559191
    [Abstract] [Full Text] [Related]

  • 11. Kinetic and metabolic aspects of enalapril action.
    Lant AF, McNabb RW, Noormohamed FH.
    J Hypertens Suppl; 1984 Dec 01; 2(2):S37-42. PubMed ID: 6100875
    [Abstract] [Full Text] [Related]

  • 12. The modified dipeptide, enalapril, an angiotensin-converting enzyme inhibitor, is transported by the rat liver organic anion transport protein.
    Pang KS, Wang PJ, Chung AY, Wolkoff AW.
    Hepatology; 1998 Nov 01; 28(5):1341-6. PubMed ID: 9794920
    [Abstract] [Full Text] [Related]

  • 13. Noncompetitive inhibition of cephradine uptake by enalapril in rabbit intestinal brush-border membrane vesicles: an enalapril specific inhibitory binding site on the peptide carrier.
    Yuasa H, Fleisher D, Amidon GL.
    J Pharmacol Exp Ther; 1994 Jun 01; 269(3):1107-11. PubMed ID: 8014854
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: effects of haemodialysis.
    Kelly JG, Doyle GD, Carmody M, Glover DR, Cooper WD.
    Br J Clin Pharmacol; 1988 Dec 01; 26(6):781-6. PubMed ID: 2853960
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.
    Greenbaum R, Zucchelli P, Caspi A, Nouriel H, Paz R, Sclarovsky S, O'Grady P, Yee KF, Liao WC, Mangold B.
    Br J Clin Pharmacol; 2000 Jan 01; 49(1):23-31. PubMed ID: 10606834
    [Abstract] [Full Text] [Related]

  • 16. Rapid conversion of the new angiotensin converting enzyme inhibitor ramipril to its active metabolite in rats.
    Tabata S, Yamazaki H, Ohtake Y, Hayashi S.
    Arzneimittelforschung; 1990 Aug 01; 40(8):865-7. PubMed ID: 2173610
    [Abstract] [Full Text] [Related]

  • 17. Compared properties of trandolapril, enalapril, and their diacid metabolites.
    Chevillard C, Jouquey S, Bree F, Mathieu MN, Stepniewski JP, Tillement JP, Hamon G, Corvol P.
    J Cardiovasc Pharmacol; 1994 Aug 01; 23 Suppl 4():S11-5. PubMed ID: 7527095
    [Abstract] [Full Text] [Related]

  • 18. Carrier-mediated transport mechanism of foscarnet (trisodium phosphonoformate hexahydrate) in rat intestinal tissue.
    Swaan PW, Tukker JJ.
    J Pharmacol Exp Ther; 1995 Jan 01; 272(1):242-7. PubMed ID: 7815338
    [Abstract] [Full Text] [Related]

  • 19. Age and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.
    Hockings N, Ajayi AA, Reid JL.
    Br J Clin Pharmacol; 1986 Apr 01; 21(4):341-8. PubMed ID: 3011046
    [Abstract] [Full Text] [Related]

  • 20. Comparative pharmacokinetics of enalapril and lisinopril, alone and with hydralazine.
    McLean AJ, Drummer OH, Smith HJ, Froomes P, McNeil JJ.
    J Hum Hypertens; 1989 Jun 01; 3 Suppl 1():147-51. PubMed ID: 2550637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.